nach oben

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Erschienen in:

02.05.2017 | Direkte orale Antikoagulanzien | CME

Intrazerebrale Blutungen unter oraler Antikoagulation

verfasst von: Dr. C. Beynon, A. W. Unterberg

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Auftreten einer intrazerebralen Blutung unter oraler Antikoagulation ist mit einer hohen Mortalität und einem ungünstigem neurologischem Outcome assoziiert. Eine herabgesetzte Koagulabilität muss frühzeitig identifiziert und behandelt werden, da diese zu einem Größenprogress intrazerebraler Hämatome und somit zu einer sekundären Hirnschädigung führen kann. Neben der Substitution von Gerinnungsfaktoren stellt das intensivmedizinische Management einen bedeutenden Eckpfeiler der Therapie dieses Patientenkollektivs dar.

Tanislav C, Milde S, Schwartzkopff S, Sieweke N, Krämer HH, Juenemann M, Misselwitz B, Kaps M (2014) Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice. BMC Neurol 14:195CrossRefPubMedPubMedCentral

Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC, Stijnen T, Lip GYH, Witteman JCM (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27(8):949–953CrossRefPubMed

Marini C, Santis FD, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke results from a population-based study. Stroke 36(6):1115–1119CrossRefPubMed

Medi C, Hankey GJ, Freedman SB (2010) Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke 41(11):2705–2713CrossRefPubMed

Cervera A, Amaro S, Chamorro A (2012) Oral anticoagulant-associated intracerebral hemorrhage. J Neurol 259(2):212–224CrossRefPubMed

Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151CrossRefPubMed

Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104CrossRefPubMed

Granger CB, Alexander JH, McMurray JJV et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981–992CrossRefPubMed

Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891CrossRefPubMed

10.

García-Rodríguez LA, Gaist D, Morton J, Cookson C, González-Pérez A (2013) Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology 81(6):566–574CrossRefPubMed

11.

Flaherty ML, Tao H, Haverbusch M et al (2008) Warfarin use leads to larger intracerebral hematomas. Neurology 71(14):1084–1089CrossRefPubMedPubMedCentral

12.

Kuramatsu JB, Gerner ST, Schellinger PD et al (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313(8):824–836CrossRefPubMed

13.

Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164(8):880–884CrossRefPubMed

14.

Beynon C, Sakowitz OW, Störzinger D, Orakcioglu B, Radbruch A, Potzy A, Unterberg AW (2015) Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb Res 136(3):560–565CrossRefPubMed

15.

Purrucker JC, Haas K, Rizos T et al (2016) Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurol 73(2):169–177CrossRefPubMed

16.

Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120(11):897–902CrossRefPubMed

17.

Jönsson AK, Spigset O, Jacobsson I, Hägg S (2007) Cerebral haemorrhage induced by warfarin – the influence of drug-drug interactions. Pharmacoepidemiol Drug Saf 16(3):309–315CrossRefPubMed

18.

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH (2010) A novel user-friendly score (HAS-BLED) to assess 1‑year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100CrossRefPubMed

19.

Apostolakis S, Lane DA, Guo Y, Buller H, Lip GYH (2012) Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 60(9):861–867CrossRefPubMed

20.

Huge V (2016) Critical care management of intracerebral hemorrhage. Med Klin Intensivmed Notfmed. doi:10.1007/s00063-016-0154-z PubMed

21.

Rizos T, Jenetzky E, Herweh C, Hug A, Hacke W, Steiner T, Veltkamp R (2010) Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage. Ann Neurol 67(6):788–793PubMed

22.

Theusinger OM, Schröder CM, Eismon J, Emmert MY, Seifert B, Spahn DR, Baulig W (2013) The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage. Anesth Analg 117(2):314–321CrossRefPubMed

23.

Kawano-Castillo J, Ward E, Elliott A et al (2014) Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement. Stroke 45(3):683–688CrossRefPubMedPubMedCentral

24.

Ebner M, Peter A, Spencer C et al (2015) Point-of-care testing of coagulation in patients treated with non-vitamin K antagonist oral anticoagulants. Stroke 46(10):2741–2747CrossRefPubMed

25.

Goldstein JN, Refaai MA, Milling TJ, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R (2015) Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet 385(9982):2077–2087CrossRefPubMed

26.

Dentali F, Marchesi C, Pierfranceschi MG et al (2011) Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 106(3):429–438CrossRefPubMed

27.

Spahn DR, Bouillon B, Cerny V et al (2013) Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 17(2):R76CrossRefPubMedPubMedCentral

28.

Steiner T, Poli S, Griebe M et al (2016) Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol 15(6):566–573CrossRefPubMed

29.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358(20):2127–2137CrossRefPubMed

30.

Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32CrossRefPubMed

31.

Illanes S, Zhou W, Schwarting S, Heiland S, Veltkamp R (2011) Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage. Stroke 42(1):191–195CrossRefPubMed

32.

Flordal PA, Sahlin S (1993) Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg 80(6):723–724CrossRefPubMed

33.

Pollack CV, Reilly PA, Eikelboom J et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373(6):511–520CrossRefPubMed

34.

Connolly SJ, Milling TJ, Eikelboom JW et al (2016) Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med 375(12):1131–1141CrossRefPubMed

35.

Orakcioglu B, Uozumi Y, Unterberg A (2011) Endoscopic intra-hematomal evacuation of intracerebral hematomas – a suitable technique for patients with coagulopathies. Acta Neurochir Suppl (Wien) 112:3–8CrossRef

36.

Samadani U, Uzma N, Rohde I, St Clair E, Samadani U (2009) Fibrinolytic therapy versus craniotomy for anticoagulant-associated intracerebral hemorrhage. Clin Neurol Neurosurg 111(6):518–522CrossRefPubMed

37.

Hemphill JC, Greenberg SM, Anderson CS et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46(7):2032–2060CrossRefPubMed

38.

Prabhakaran S, Herbers P, Khoury J, Adeoye O, Khatri P, Ferioli S, Kleindorfer DO (2015) Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage? Stroke 46(2):369–375CrossRefPubMed

39.

Romualdi E, Micieli E, Ageno W, Squizzato A (2009) Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost 101(2):290–297PubMed

40.

Reddy VY, Sievert H, Halperin J et al (2014) Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312(19):1988–1998CrossRefPubMed

Titel: Intrazerebrale Blutungen unter oraler Antikoagulation
verfasst von: Dr. C. Beynon
A. W. Unterberg
Publikationsdatum: 02.05.2017
Verlag: Springer Medizin
Schlagwörter: Direkte orale Antikoagulanzien
Apoplex
Hirnblutung
Antikoagulanzien
Orale Antikoagulanzien
Warfarin
Direkte orale Antikoagulanzien
Tranexamsäure
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 5/2017
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI: https://doi.org/10.1007/s00063-017-0293-x

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Serum IgG levels and mortality in patients with severe sepsis and septic shock

Qualitätsindikatoren und strukturelle Voraussetzungen für Cardiac-Arrest-Zentren – Deutscher Rat für Wiederbelebung/German Resuscitation Council (GRC)

Extrakorporale Therapien bei Lebererkrankungen

Nierenersatztherapie im akuten Nierenversagen

Plasmapherese zur Behandlung einer hypertriglyzeridämiebedingten Pankreatitis

Die Sepsisleitlinie der Surviving Sepsis Campaign 2016